Fluvoxamine versus desipramine: comparative polysomnographic effects. 1991

D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, PA 15213.

Electroencephalogram sleep measures over a 4-week period were obtained on 35 inpatients with major depression (unipolar) who received either fluvoxamine or desipramine in a randomized double-blind trial. Fluvoxamine showed immediate rapid eye movement (REM) sleep suppression and an alerting effect on sleep continuity measures. In contrast, desipramine administration was associated with REM suppression and sleep continuity improvement. The "alerting" quality of fluvoxamine, similar to other serotonergic antidepressants, appears to be unrelated to a lack of clinical efficacy, but may be related to persistent REM sleep suppression. However, it is premature to comment on the serotonin specificity for REM sleep.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010091 Oximes Compounds that contain the radical R2C Aldoximes,Hydroxyimino Compounds,Ketoxime,Ketoximes,Oxime,Compounds, Hydroxyimino
D003700 Delta Rhythm Brain waves seen on EEG characterized by a high amplitude and a frequency of 4 Hz and below. They are considered the "deep sleep waves" observed during sleep in dreamless states, infancy, and in some brain disorders. Delta Rhythms,Rhythm, Delta,Rhythms, Delta
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003891 Desipramine A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. Desmethylimipramine,Apo-Desipramine,Demethylimipramine,Desipramine Hydrochloride,Norpramin,Novo-Desipramine,Nu-Desipramine,PMS-Desipramine,Pertofran,Pertofrane,Pertrofran,Petylyl,Ratio-Desipramine,Apo Desipramine,Hydrochloride, Desipramine,Novo Desipramine,Nu Desipramine,PMS Desipramine,Ratio Desipramine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
November 2005, Behavioural pharmacology,
D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
November 1990, Forensic science international,
D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
June 1992, Therapeutic drug monitoring,
D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
December 2008, Behavioural pharmacology,
D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
December 1991, Schweizerische medizinische Wochenschrift,
D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
September 2004, Journal of psychopharmacology (Oxford, England),
D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
February 1994, British journal of clinical pharmacology,
D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
September 1993, Clinical pharmacology and therapeutics,
D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
April 2011, Movement disorders : official journal of the Movement Disorder Society,
D J Kupfer, and J M Perel, and B G Pollock, and R S Nathan, and V J Grochocinski, and M J Wilson, and A B McEachran
February 2008, Behavioural pharmacology,
Copied contents to your clipboard!